EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico
NCT ID: NCT06386432
Last Updated: 2025-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2025-12-01
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CommunityRx-Cardiovascular Disease
NCT06264726
Health Equity and Rural Education (HERE!) Clinical Trial
NCT06460116
Equitable Access to COVID-19 Vaccines
NCT04952376
Community Care Intervention to Decrease COVID-19 Vaccination Inequities
NCT06156254
Chronic Care Management for Adults at FQHCs
NCT02136732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants are randomized to 1 of 2 groups.
GROUP I: Participants receive access to a self-guided, smartphone app-delivered quit smoking program, called EQQUAL-NM (Program A) that helps explore personal values and teaches participants about smoking triggers and skills to help them manage cravings and accept thoughts and feelings related to smoking. Participants receive text message reminders and prompts on study. Some participants also undergo collection of a saliva sample during follow-up.
GROUP II: Participants receive access to a self-guided, smartphone app-delivered quit smoking program, called EQQUAL-NM (Program B) that is based on current clinical practice guidelines for tobacco cessation to help them quit smoking. This program helps with quit advice, tracking progress on quitting smoking, and managing cravings. Participants receive text message reminders and prompts on study. Some participants also undergo collection of a saliva sample during follow-up.
After completion of study intervention, patients are followed up at 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (EQQUAL-NM, Program A)
Participants receive self-guided smartphone app-delivered EQQUAL-NM (Program A) intervention on study. Participants also receive motivational messages, reminders and smoking cessation information via text messages. Some participants also complete at-home saliva sample collection during follow-up.
Smartphone App-delivered Smoking Cessation Intervention
Receive access to EQQUAL-NM (Program A) intervention
Health Promotion and Education
Receive text message reminders, motivational messages and prompts via SMS text messages (Program A)
Biospecimen Collection
Complete at-home saliva sample collection
Questionnaire Administration
Ancillary studies
Arm II (EQQUAL-NM, Program B)
Participants receive self-guided smartphone app-delivered EQQUAL-NM (Program B) intervention on study. Participants also receive motivational messages, reminders and smoking cessation information via text messages. Some participants also complete at-home saliva sample collection during follow-up.
Smartphone App-delivered Smoking Cessation Intervention
Receive access to EQQUAL-NM (Program B) intervention
Health Promotion and Education
Receive text message reminders, motivational messages and prompts via SMS text messages (Program B)
Biospecimen Collection
Complete at-home saliva sample collection
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smartphone App-delivered Smoking Cessation Intervention
Receive access to EQQUAL-NM (Program A) intervention
Smartphone App-delivered Smoking Cessation Intervention
Receive access to EQQUAL-NM (Program B) intervention
Health Promotion and Education
Receive text message reminders, motivational messages and prompts via SMS text messages (Program A)
Health Promotion and Education
Receive text message reminders, motivational messages and prompts via SMS text messages (Program B)
Biospecimen Collection
Complete at-home saliva sample collection
Questionnaire Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identify as a sexual and/or gender minority (i.e., a sexual orientation other than straight and/or gender that doesn't match sex assigned at birth)
* Currently reside in New Mexico, with a New Mexico mailing address, and anticipate remaining in New Mexico for the duration of the study (3 months)
* Self-report smoking at least 1 cigarette per week in the 30 days prior to screening
* Own an Android phone or iPhone
* Have at least weekly internet access for the next three months
* Willing and able to stream audio and video for this study
* Current use of a personal email account
* Current use of text messaging
* Interested in participating in the study for themselves (versus \[vs\] someone else)
* Self-report that they have not participated in one of Fred Hutch's/NMSU's prior smoking cessation studies
* Understand and agree to the conditions of compensation
* Currently not incarcerated
* Participants must be willing to use the assigned intervention program, complete the study assessments, and agree to the online consent form in English
Exclusion Criteria
* Member of the same household as another research participant
* Previous use of the National Cancer Institute (NCI) QuitGuide app
* Google voice number as sole phone number
* Does not pass study fraud prevention protocol
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
National Cancer Institute Center to Reduce Cancer Health Disparities
UNKNOWN
New Mexico State University
OTHER
Fred Hutchinson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaimee Heffner
Role: PRINCIPAL_INVESTIGATOR
Fred Hutch/University of Washington Cancer Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-02453
Identifier Type: REGISTRY
Identifier Source: secondary_id
FHIRB0020404
Identifier Type: OTHER
Identifier Source: secondary_id
RG1124189
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.